Testing effectiveness (Phase 2)Study completedNCT00665314
What this trial is testing
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
Who this might be right for
LymphomaNon Hodgkin's LymphomaHodgkin's Disease+1 more
Genzyme, a Sanofi Company 5